Project Details
Description
The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) was launched in 2015 and brings together several academic research institutions and hospitals in Europe. GPPAD aims to establish an international infrastructure for studies dedicated to preventing the development of type 1 diabetes.
| Status | Active |
|---|---|
| Effective start/end date | 2015/01/01 → … |
Collaborative partners
- Lund University (lead)
- Helmholtz Zentrum München
- Diabeteszentrum für Kinder und Jugendliche
- Dresden University of Technology
- University Hospitals Leuven
- Royal Victoria Infirmary
- University of Oxford
- National Research Institute of Mother and Child
- Medical University of Warsaw
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
UKÄ subject classification
- Endocrinology and Diabetes